What the New Medicare Prescription Drug Cap Actually Means for Your Wallet

The questions below cover what people most want to know — without the insurance-industry jargon. Each answer is followed by the fuller picture for anyone who needs it.

• 1
  What is the Medicare Part D out-of-pocket cap right now? $2,100 for the current plan year · $0 after you hit the cap · Applies to all stand-alone Part D plans and Medicare Advantage drug coverage

  The out-of-pocket maximum for covered Part D prescription drugs is $2,100 for the current plan year. Once your spending on covered drugs — counting your deductible, copays, and coinsurance — reaches that amount, you pay absolutely nothing for covered Part D drugs for the rest of the calendar year. That $2,100 figure replaced the previous $2,000 cap from last year, adjusted for changes in average drug spending. Going forward, the cap will be updated each year using a similar formula. It applies whether you have a stand-alone Part D prescription drug plan or drug coverage bundled into a Medicare Advantage plan. Monthly premiums do not count toward the cap — only what you actually pay at the pharmacy counter does.
• 2
  Is the old “donut hole” really gone? Yes, permanently — eliminated as of 2025 · Part D now has just three straightforward phases instead of four

  The coverage gap — the stretch where you once paid a higher share of drug costs after initial coverage ran out — no longer exists. It was eliminated permanently starting in 2025 and does not return. Part D now has three phases instead of four: a deductible phase where you pay the full cost up to your plan’s deductible (the maximum allowed is $615 for the current year, though many plans set it lower or eliminate it for generics); an initial coverage phase where you pay roughly 25% of covered drug costs until your out-of-pocket total reaches $2,100; and catastrophic coverage, where your plan pays 100% of covered drug costs for the rest of the year. That’s it. The confusing four-phase structure that caught so many people off guard mid-year is gone.
• 3
  Which drugs now cost less because Medicare negotiated their prices? 10 drugs: Eliquis, Jardiance, Xarelto, Januvia, Farxiga, Entresto, Enbrel, Imbruvica, Stelara, and NovoLog/Fiasp insulin · Discounts of 38–79% off list price · Nearly 9 million people affected

  For the first time in the program’s history, Medicare negotiated directly with drug manufacturers and the resulting lower prices took effect January 1 of this year. The 10 drugs selected for this first round treat some of the most common chronic conditions in older Americans: blood clots and stroke prevention (Eliquis, Xarelto), diabetes (Jardiance, Januvia, Farxiga, NovoLog/Fiasp insulin), heart failure (Entresto), rheumatoid arthritis (Enbrel), blood cancer (Imbruvica), and inflammatory diseases including Crohn’s and psoriasis (Stelara). These negotiated prices are Maximum Fair Prices — your plan cannot charge you more than these amounts for the drug itself. What you actually pay at the pharmacy also depends on your plan’s tier placement and your deductible status, which is why some enrollees have reported confusion when their specific plan’s copay doesn’t perfectly mirror the published Maximum Fair Price. If you’re on any of these medications and believe you’re being overcharged, contact your plan or call your State Health Insurance Assistance Program (SHIP) for free help navigating it.
• 4
  What actually counts toward the $2,100 cap? Your deductible payments · Your copays and coinsurance on covered drugs · Certain payments made on your behalf through Extra Help · What does NOT count: your monthly premium, manufacturer coupons, spending on non-covered drugs

  Understanding what counts — and what doesn’t — toward the cap matters because it directly affects when you stop paying. Your annual deductible, every copay, and every coinsurance payment you make on covered Part D drugs all count. If you receive Extra Help (the Low Income Subsidy program), certain payments made on your behalf also count, which can help lower-income beneficiaries reach the cap faster. What does not count: your monthly Part D premium, any amounts paid through a manufacturer’s coupon or patient assistance program, and spending on drugs that are not covered by your plan. The most important practical tip here is to use a preferred pharmacy in your plan’s network — preferred pharmacies offer lower copays, which means you spend less before hitting the cap and keep more money in your pocket if you never reach $2,100.
• 5
  What is the Medicare Prescription Payment Plan and should I use it? It spreads your drug costs into equal monthly payments across the year · No interest, no fees · Now auto-renews · Doesn’t lower total cost — just smooths cash flow for fixed incomes

  Even with a $2,100 annual cap, the timing of drug costs can create real hardship. If you have a deductible and fill an expensive prescription in January, you might owe several hundred dollars at once before your plan starts picking up more of the tab. The Medicare Prescription Payment Plan — sometimes called the M3P or “smoothing” option — addresses exactly this problem. Instead of paying large amounts upfront at the pharmacy, your out-of-pocket costs for the year are divided into equal monthly installments and billed by your plan. There’s no interest and no fees. It doesn’t reduce what you ultimately owe — it just changes when you pay it. Participation now automatically renews from year to year unless you opt out. You can also enroll retroactively at any point in the year if an unexpected prescription triggers a large pharmacy bill. If you live on Social Security income and a surprise $400 pharmacy bill in January would strain your budget, the payment plan is worth signing up for.
• 6
  I have a low income — is there extra help beyond the $2,100 cap? Yes — Extra Help (Low Income Subsidy) reduces premiums, deductibles, and copays significantly · Income threshold: roughly $21,870/year for individuals · Apply through Social Security at ssa.gov · Generic copays as low as $5.10 per prescription

  The $2,100 cap helps everyone with Part D, but for people with limited incomes, Extra Help — also called the Low Income Subsidy — goes much further. If your annual income falls below approximately $21,870 for a single person (or around $29,580 for a couple), and your savings and investments are relatively modest, you may qualify for Extra Help. Full Extra Help can reduce your generic drug copays to just $5.10 per prescription and brand-name copays to $12.65 — far below what most standard plans charge. It also helps with your monthly premium and eliminates or significantly reduces your deductible. Eligibility has been expanded in recent years, so even if you were denied in the past, it’s worth reapplying. You apply through Social Security — online at ssa.gov, by phone at 1-800-772-1213, or in person at your local Social Security office. Applications are free and you will never be asked to pay a fee to apply.
• 7
  Does the cap apply if I’m in a Medicare Advantage plan? Yes — the $2,100 drug cap applies to the Part D drug portion of all Medicare Advantage plans that include prescription drug coverage (MA-PD plans)

  If your Medicare Advantage plan includes prescription drug coverage — which most do, and those plans are called MA-PD plans — the same $2,100 out-of-pocket cap applies to the drug benefit portion of your plan. What Medicare Advantage plans also carry separately is an overall medical out-of-pocket maximum (called MOOP), which covers doctor visits, hospital stays, and other medical services — that limit is set differently and varies by plan. So in a Medicare Advantage plan, you have two separate out-of-pocket calculations running simultaneously: one tracking your drug costs toward the $2,100 drug cap, and one tracking your medical costs toward the plan’s MOOP limit. Understanding which bucket a given expense falls into — drug or medical — helps you anticipate when your costs for that category will stop for the year.
• 8
  Who benefits most from the new cap — and who barely notices it? Biggest benefit: people on high-cost specialty drugs (cancer, autoimmune, MS, blood thinners) who previously owed thousands before catastrophic coverage · Modest benefit: people with average chronic conditions · Little change: people whose total drug spending stays below $2,100 anyway

  The cap is genuinely transformative for a specific group: people whose medications are expensive enough that they previously reached — or would never reach — the old $8,000 catastrophic threshold. Before the current rules, someone taking Stelara for Crohn’s disease or Imbruvica for blood cancer could owe thousands of dollars in a single month before catastrophic coverage engaged. Today, their annual drug out-of-pocket is capped. For people with common chronic conditions — high blood pressure, standard-tier diabetes medications, cholesterol drugs — whose annual drug spending stays comfortably under $2,100, the everyday experience at the pharmacy won’t change much. The cap’s value for this group is as insurance: if a new diagnosis, a surgery, or a course of expensive antibiotics pushes costs higher mid-year, the ceiling protects them. Nearly 3.2 million Americans benefited from the cap in its first year, and that number grows as more specialty drugs are added to negotiations in coming years.

Part D used to have four confusing phases. The donut hole is gone. Here is exactly what happens — and what you pay — at each step of your coverage year.

These are the 10 drugs whose prices Medicare negotiated directly with manufacturers. The Maximum Fair Price is the ceiling — no plan can charge more than this for the drug itself. Your actual copay depends on your plan’s tier and whether you’ve met your deductible.

Use the buttons below to locate Medicare counselors, Social Security offices, and pharmacies that accept your plan in your area. Free counseling is available — you never need to pay for Medicare enrollment help.